François Leteurtre

2.1k citations

32 papers · 1.7k indexed · 1 hit paper · h-index 21

Co-authors: Yves Pommier Kurt W. Kohn Mark R. Fesen Glenda Kohlhagen Akihiko Tanizawa Éliane Gluckman Kenneth D. Paull Monroe E. Wall
Topics: Cancer therapeutics and mechanisms (14 papers)DNA Repair Mechanisms (8 papers)Bioactive Compounds and Antitumor Agents (5 papers)
Cited by: Toxicology Virology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological ChemistrySHILAP Revista de lepidopterología
Partner nations: France United States Poland

In The Last Decade

François Leteurtre

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds

1994 292 citations Mark R. Fesen, Yves Pommier et al. Biochemical Pharmacology profile →

Peers

Countries citing papers authored by François Leteurtre

Since Specialization

Citations

This map shows the geographic impact of François Leteurtre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Leteurtre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Leteurtre more than expected).

Fields of papers citing papers by François Leteurtre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Leteurtre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Leteurtre. The network helps show where François Leteurtre may publish in the future.

Co-authorship network of co-authors of François Leteurtre

This figure shows the co-authorship network connecting the top 25 collaborators of François Leteurtre. A scholar is included among the top collaborators of François Leteurtre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Leteurtre. François Leteurtre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OGG1 competitive inhibitors show important off-target effects by directly inhibiting efflux pumps and disturbing mitotic progression 2023 ·Frontiers in Cell and Developmental Biology ·(unknown),Guillaume Pinna,Marie Vandamme,(unknown),(unknown),Anne Marie Di Guilmi,J. Pablo Radicella,B. Castaing,Rebecca Smith,Sébastien Huet,François Leteurtre,Anna Campalans	6
2	APP deficiency and HTRA2 modulates PrPc proteostasis in human cancer cells 2021 ·SHILAP Revista de lepidopterología ·Denis Biard,Rafika Jarray,(unknown),François Leteurtre,Dulce Papy-García	1
3	“Clickable” Hydrosoluble PEGylated Cryptophane as a Universal Platform for ¹²⁹Xe Magnetic Resonance Imaging Biosensors 2013 ·Chemistry - A European Journal ·(unknown),Naoko Kotera,(unknown),Sébastien Garcia‐Argote,Céline Puente,François Leteurtre,Edmond Gravel,Nawal Tassali,Céline Boutin,Estelle Léonce,Yves Boulard,Patrick Berthault,Bernard Rousseau	16
4	Cell uptake of a biosensor detected by hyperpolarized 129Xe NMR: The transferrin case 2011 ·Bioorganic & Medicinal Chemistry ·Céline Boutin,Antoine Stopin,(unknown),Thierry Brotin,Jean‐Pierre Dutasta,Nadège Jamin,Alain Sanson,Yves Boulard,François Leteurtre,Gaspard Huber,(unknown),Nawal Tassali,Hervé Desvaux,Marie Carrière,Patrick Berthault	70
5	Hyperpolarized ¹²⁹Xe NMR signature of living biological cells 2011 ·NMR in Biomedicine ·Céline Boutin,Hervé Desvaux,Marie Carrière,François Leteurtre,Nadège Jamin,Yves Boulard,Patrick Berthault	31
6	Two distinctly altered cellular responses to DNA double-strand breaks in human neuroblastoma 2008 ·Biochimie ·(unknown),François Leteurtre,(unknown),Jean Bénard,Mounira Amor-Guéret	10
7	The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase 2006 ·Oncogene ·(unknown),Véronique Berthonaud,Anne Chevalier,Cécile Ducrot,(unknown),Carl Mann,François Leteurtre	81
8	Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia 2003 ·British Journal of Haematology ·Xiaxin Li,François Leteurtre,Vanderson Rocha,Philippe Guardiola,Roland Berger,Marie‐Thérèse Daniel,(unknown),Odile Maarek,G. Le Roux,Pauline de La Salmonière,Patrice Richard,Éliane Gluckman	36
9	In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34+ cord blood cells 2000 ·Experimental Hematology ·Ladan Kobari,Françoise Pflumio,Marie‐Catherine Giarratana,Xiaxin Li,Monique Titeux,Brigitte Izac,François Leteurtre,Laure Coulombel,Luc Douay	56
10	Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells 1997 ·Leukemia ·François Leteurtre,(unknown),Éliane Gluckman,(unknown)	56
11	Azatoxin derivatives with potent and selective action on topoisomerase II 1995 ·Biochemical Pharmacology ·François Leteurtre,Dan L. Sackett,José S. Madalengoitia,Glenda Kohlhagen,Timothy L. Macdonald,Ernest Hamel,Kenneth D. Paull,Yves Pommier	30
12	Differential Stabilization of Eukaryotic DNA Topoisomerase I Cleavable Complexes by Camptothecin Derivatives 1995 ·Biochemistry ·Akihiko Tanizawa,Kurt W. Kohn,Glenda Kohlhagen,François Leteurtre,Yves Pommier	110
13	DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors 1995 ·Mutation Research/DNA Repair ·Yves Pommier,Jeffrey L. Jenkins,Glenda Kohlhagen,François Leteurtre	41
14	Cellular pharmacology of azatoxins (topoisomerase‐II and tubulin inhibitors) in P‐glycoprotein‐positive and ‐negative cell lines 1995 ·International Journal of Cancer ·Béatrice Eymin,Éric Solary,Sylvie Chevillard,Laurence Dubrez,François Goldwasser,Olivier Duchamp,Philippe Genne,François Leteurtre,Yves Pommier	14
15	Streptonigrin-Induced Topoisomerase II Sites Exhibit Base Preferences in the Middle of the Enzyme Stagger 1994 ·Biochemical and Biophysical Research Communications ·François Leteurtre,Glenda Kohlhagen,Yves Pommier	12
16	Topoisomerase II Inhibition and Cytotoxicity of the Anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute Preclinical Antitumor Drug Discovery Screen 1994 ·JNCI Journal of the National Cancer Institute ·François Leteurtre,Glenda Kohlhagen,Kenneth D. Paull,Yves Pommier	64
17	Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. 1994 ·Journal of Biological Chemistry ·François Leteurtre,A. Fujimori,Akihiko Tanizawa,(unknown),Abhijit Mazumder,Glenda Kohlhagen,Hiroyuki Nakano,Yves Pommier	55
18	Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compoundsbreakdown → 1994 ·Biochemical Pharmacology ·Mark R. Fesen,Yves Pommier,François Leteurtre,(unknown),(unknown),Kurt W. Kohn	292
19	Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent 1993 ·Biochemical Pharmacology ·Éric Solary,François Leteurtre,Kenneth D. Paull,Dominic A. Scudiero,Ernest Hamel,Yves Pommier	40
20	Specific interaction of camptothecin, a topoisomerase I inhibitor, with guanine residues of DNA detected by photoactivation at 365 nm 1993 ·Biochemistry ·François Leteurtre,Mark R. Fesen,Glenda Kohlhagen,Kurt W. Kohn,Yves Pommier	42

About François Leteurtre

François Leteurtre is a scholar working on Toxicology, Oncology and Molecular Biology, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), DNA Repair Mechanisms (8 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Toxicology (252 citations), Virology (205 citations) and Molecular Biology (1.1k citations). François Leteurtre has collaborated with scholars based in France, United States and Poland. Frequent co-authors include Yves Pommier, Kurt W. Kohn, Mark R. Fesen, Glenda Kohlhagen, Akihiko Tanizawa, Éliane Gluckman, Kenneth D. Paull, Monroe E. Wall, Mansukh C. Wani and G. Le Roux. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact